Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis.
about
Redox balance dynamically regulates vascular growth and remodelingPeroxiredoxin isoforms are associated with cardiovascular risk factors in type 2 diabetes mellitusThioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signalingParadoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health ImplicationsADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in miceNitrosative stress induces peroxiredoxin 1 ubiquitination during ischemic insult via E6AP activation in endothelial cells both in vitro and in vivo.Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient miceMouse Models of Oxidative Stress Indicate a Role for Modulating Healthy Aging.Helminth infection in populations undergoing epidemiological transition: a friend or foe?Peroxiredoxin 4, a novel circulating biomarker for oxidative stress and the risk of incident cardiovascular disease and all-cause mortality.Protein targets of acrylamide adduct formation in cultured rat dopaminergic cells.Targeting cellular antioxidant enzymes for treating atherosclerotic vascular disease.Novel links among peroxiredoxins, endothelial dysfunction, and severity of atherosclerosis in type 2 diabetic patients with peripheral atherosclerotic disease.Cell stress proteins in atherothrombosisMolecular biology of atherosclerosis.ROS signaling and redox biology in endothelial cells.Discovering Antioxidant Molecules in the Archaea Domain: Peroxiredoxin Bcp1 from Sulfolobus solfataricus Protects H9c2 Cardiomyoblasts from Oxidative Stress.Ramalin inhibits VCAM-1 expression and adhesion of monocyte to vascular smooth muscle cells through MAPK and PADI4-dependent NF-kB and AP-1 pathways.Responses to reductive stress in the cardiovascular system.Comparative proteomics analysis of mice lymphocytes in early stages of infection by different strains of rabies virus.Overexpression of peroxiredoxin 4 attenuates atherosclerosis in apolipoprotein E knockout mice.Targeting endogenous antioxidants to prevent cardiovascular diseasesRegulation of phosphatidylinositol-5-phosphate signaling by Pin1 determines sensitivity to oxidative stress.Reactive oxygen species: finding the right balance.Deficiency of TDAG51 protects against atherosclerosis by modulating apoptosis, cholesterol efflux, and peroxiredoxin-1 expression.The absence of macrophage Nrf2 promotes early atherogenesis.Prdx1 (peroxiredoxin 1) deficiency reduces cholesterol efflux via impaired macrophage lipophagic flux.Oxidative Stress in Cardiovascular Diseases: Involvement of Nrf2 Antioxidant Redox Signaling in Macrophage Foam Cells Formation.Association of DJ-1/PTEN/AKT- and ASK1/p38-mediated cell signalling with ischaemic cardiomyopathy.Impact of SIN-1-derived peroxynitrite flux on endothelial cell redox homeostasis and bioenergetics: protective role of diphenyl diselenide via induction of peroxiredoxins.Role of Peroxiredoxin 2 in the Protection Against Ferrous Sulfate-Induced Oxidative and Inflammatory Injury in PC12 Cells.
P2860
Q27004547-FBF87516-A6CE-4468-8A43-95E12D492E92Q28258316-4F9F6383-6B0B-4607-B95A-74A6E0958195Q28389739-202AC3D4-8FD3-424E-A91F-528866CFB650Q28392715-CEA24627-F66C-47A7-8227-E3C862E9DCA0Q30511960-BA58A772-286A-4A1A-BE06-0A1F3CDA1B1FQ33722929-A077214E-26C3-4C46-811C-63DF82E0C1CEQ33810234-3D0C74DC-C662-416A-86FF-11A900BC6F36Q34300952-DE09AF09-243C-4DAF-9071-8E0174580134Q34467996-5E2BDC6A-C62F-45C7-94BD-76FF3A1B0F50Q36522598-67A8D2E4-8992-4A82-8AC3-E27420168C16Q37000219-6D0FB143-C91B-41E7-A915-64460C3B0786Q37145594-DE25E9F7-5FD0-4FFD-A2A6-54C2CB15D71AQ37601145-D3BFE50D-BFF5-4996-B65B-8062618DD3E1Q38026043-EF69E3D1-4697-4D4A-A738-28526B31B895Q38125279-0EA8CB71-4B28-494C-9BE1-5266ECFB4B1FQ38478574-6BC98E6D-18FF-489F-A5EC-3C82654BD0CCQ38740353-9234F50D-7F85-431C-B954-54DC2FCE6C10Q38930168-F6DE9CE1-B363-49E6-9098-8C2620314C11Q39035367-D0C32E3D-0973-4F05-B428-DC307C98772FQ41967690-EA43B2EC-8B6C-4137-8BB8-E6CDD0554EB3Q42116622-F005F1F5-63DE-4DD9-BEF4-0F3E970D0ED0Q42588905-2C6A4A5E-B94A-4E47-BCBE-71CF881691E6Q42678633-13B70900-411C-41CA-814C-C37190BB0655Q43068834-47C51F9D-4A90-4110-A5D0-9D3FEBA95ED3Q43109046-C284E671-5630-4A8B-9DCD-B35D65E9AB7EQ43901244-EA7921CC-BD1E-4272-9C29-0AF95A1B34CCQ45981930-FCB7AC10-310B-4957-9427-BF8AC25F034FQ46266568-D8AD9B99-F03D-4B04-98A3-541D7A9E4BECQ46634695-38FF8129-7976-4966-9E04-C70A654BABD5Q46817535-89E89DDA-8E9B-423A-9F0B-3EDBB03D04ECQ47856535-C8D4C4C0-7EC3-430C-91F3-BD6F46C379D4
P2860
Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Peroxiredoxin1 Prevents Excessive Endothelial Activation and Early Atherosclerosis
@nl
Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis.
@ast
Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis.
@en
type
label
Peroxiredoxin1 Prevents Excessive Endothelial Activation and Early Atherosclerosis
@nl
Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis.
@ast
Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis.
@en
prefLabel
Peroxiredoxin1 Prevents Excessive Endothelial Activation and Early Atherosclerosis
@nl
Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis.
@ast
Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis.
@en
P2093
P2860
P3181
P1433
P1476
Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis
@en
P2093
Ayce Yesilaltay
Carola Neumann
Denisa D Wagner
Janka Kisucka
Monty Krieger
Richard A Van Etten
P2860
P304
P3181
P356
10.1161/CIRCRESAHA.108.174870
P577
2008-08-08T00:00:00Z